no adverse side-effects were reported and there were no significant changes in total cholesterol , triglyceride or high-density lipoprotein 3-cholesterol concentrations following 600 mg/kg clinofibrate treatment for 4 weeks in either insulin-dependent or non-insulin-dependent diabetics .
C0021641
insulin
C0011860
non-insulin-dependent diabetics